AVITA Medical Eyes Lower End Of Previously Provided 2024 Revenue Guidance Of $78.5M-$84.5M, Est $80.093M
Portfolio Pulse from Benzinga Newsdesk
AVITA Medical anticipates its 2024 revenue to be at the lower end of its previously forecasted range of $78.5M-$84.5M, with estimates around $80.093M. The company will release its Q1 2024 financial results after U.S. markets close on May 13, 2024.
April 10, 2024 | 9:17 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
AVITA Medical projects its 2024 revenue to hit the lower spectrum of its $78.5M-$84.5M guidance, with an estimated revenue of $80.093M. The Q1 2024 financial results will be disclosed after the market closes on May 13, 2024.
The announcement that AVITA Medical expects its 2024 revenue to be at the lower end of the previously provided guidance range may lead to negative investor sentiment in the short term. This adjustment in revenue expectations could be interpreted as a sign of potential challenges in achieving higher sales figures or facing market headwinds, thus likely causing a downward pressure on the stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100